Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms
10 January 2026
1 min read

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

NEW YORK, Jan 9, 2026, 21:00 EST — Market closed.

  • Marvell slipped 0.3% on Friday, dragging its loss to roughly 8% since Monday’s close
  • According to an SEC filing, Marvell’s chief legal officer offloaded 5,000 shares
  • Traders are focusing on next week’s U.S. CPI report and Marvell’s earnings due in early March as the upcoming catalysts

Marvell Technology (MRVL.O) shares slipped 0.3% on Friday following a filing revealing a stock sale by a top executive. The chipmaker has tumbled sharply since earlier this week, transforming what started as a deal-fueled rebound into fresh volatility.

These shifts matter since Marvell is deep in the data-center expansion, providing custom AI chips and networking silicon that shuttles data between servers. Investors remain uneasy about whether major cloud clients will maintain their spending pace, so Marvell’s order updates often trigger sharp stock moves.

JPMorgan analyst Harlan Sur reported that Chairman and CEO Matt Murphy described near-term AI bookings as “on fire” in a recent fireside chat. Management expects data-center growth to hit about 25% in calendar 2026, with acceleration projected for 2027. Sur also highlighted management’s forecast for custom AI revenue around $1.8 billion in 2026, doubling to roughly $3.6 billion in 2027. 1

Marvell ended the day at $83.22, slipping roughly 25 cents from its previous close, market data show.

Technicians are keeping an eye on whether the stock can maintain support around the low $82 level after Friday’s intraday dip near $82, following a peak closer to the mid-$90s earlier in the week’s selloff. 2

A Form 4 submitted on Jan. 7 revealed that EVP and Chief Legal Officer Mark Casper sold 5,000 Marvell shares on Jan. 5 at $93.08 each. After the sale, he retained 19,418 shares directly, along with more shares held via a family trust. 3

Earlier this week, Marvell announced plans to acquire networking equipment maker XConn Technologies for roughly $540 million, aiming to strengthen its AI data-center connectivity segment. CEO Matt Murphy described the deal as creating “a compelling switching platform,” highlighting the silicon technology that manages traffic routing in data centers. 4

Friday marked Marvell’s ex-dividend date for a $0.06 quarterly payout scheduled for Jan. 29, creating a minor technical factor for short-term traders. Looking ahead to Monday, macro investors are focused on the upcoming U.S. inflation data — the December 2025 CPI report is set for release on Jan. 13 — while rate forecasts remain influenced by the Federal Reserve’s policy meeting on Jan. 27–28. 5

That downside risk remains. If cloud clients pull back on orders, or if competitors such as Broadcom (AVGO.O) and Nvidia (NVDA.O) strengthen their hold on data-center networking and AI infrastructure, Marvell’s outlook could come under pressure, leaving the stock volatile.

Marvell is set to release earnings on March 4, per Nasdaq data, with investors zeroing in on data-center guidance and any news about the XConn integration timeline. 6

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next
Previous Story

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Arista Networks stock slips again as traders eye CPI and Feb. 16 earnings
Next Story

Arista Networks stock slips again as traders eye CPI and Feb. 16 earnings

Go toTop